WHO Adds Two Cancer Drugs to Essential Medicines List
The World Health Organisation says the two recently developed immunotherapies - anivolumab and pembrolizumab - have delivered up to 50% survival rates for advanced melanoma, a cancer that until recently was incurable. WHO's Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritise critical health products that should be widely available and affordable throughout health systems.
(file photo).
InFocus
-
According to Seed Global Health, over 90% of cervical cancer cases occur in low and middle-income countries. Cervical cancer is the leading cause of death for women in sub-Saharan ... Read more »
-
Non-Communicable Diseases (NCDs) are a major threat in Africa. It is estimated that there will be about 3.9 million deaths from these diseases in Africa by 2020. The burden of ... Read more »